Swallowing evaluation in patients who underwent Partial CO2 LASER Epiglottectomy for Sleep Apnea treatment

Auris Nasus Larynx. 2023 Dec;50(6):921-928. doi: 10.1016/j.anl.2023.02.004. Epub 2023 Mar 9.

Abstract

Objective: To evaluate swallowing in patients who underwent CO2 LASER Partial Epiglottectomy (CO2-LPE) for Obstructive Sleep Apnea Syndrome and to assess the risk of aspiration with this technique.

Material & methods: Chart review of adult patients who underwent CO2-LPE between 2016 and 2020, in a secondary care hospital. Patients underwent surgery for OSAS, in accordance to Drug Induced Sleep Endoscopy findings and an objective swallowing evaluation was done at least 6 months after surgery. Eating Assessment Tool (EAT-10) questionnaire was applied and Volume-Viscosity Swallow Test (V-VST) and Fiberoptic Endoscopic Evaluation of Swallowing (FEES) were performed. Dysphagia was classified according to Dysphagia Outcome Severity Scale (DOSS).

Results: Eight patients were included in the study. The mean time between surgery and the swallowing evaluation was 50 (±13,2) months. Only 3 patients presented ≥ 3 points on EAT-10 questionnaire. Two patients presented signs of decreased efficacy of swallowing (piecemeal deglutition) but none had a decrease in safety, according to V-VST. Although 50% of the patients presented some pharyngeal residue on FEES, it was classified as trace to mild in most of the cases. No evidence of penetration or aspiration was identified (DOSS ≥ 6 in all patients).

Conclusion: The CO2-LPE is a potential treatment for OSAS patients with epiglottic collapse and no evidence of swallowing safety compromise was found.

Keywords: CO2 LASER; Dysphagia; Epiglottis; LASER epiglottectomy; Swallow evaluation.

MeSH terms

  • Adult
  • Carbon Dioxide
  • Deglutition
  • Deglutition Disorders* / diagnosis
  • Deglutition Disorders* / etiology
  • Deglutition Disorders* / surgery
  • Humans
  • Lasers, Gas* / therapeutic use
  • Sleep Apnea, Obstructive* / surgery

Substances

  • Carbon Dioxide